William Hoffman - 05 Apr 2022 Form 4 Insider Report for Inari Medical, Inc.

Role: President and CEO, Director
Signature: /s/ Angela Ahmad, attorney-in-fact for
Issuer symbol: N/A
Transactions as of: 05 Apr 2022
Net transactions value: -$2,707,626
Form type: 4
Filing time: 07 Apr 2022, 16:34:12 UTC
Previous filing: 05 Apr 2022
Next filing: 09 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NARI	Common Stock	Options Exercise	$12,840	+30,000	+5.5%	$0.4280^*	580,307	05 Apr 2022	Direct	F1
transaction	NARI	Common Stock	Sale	$246,009	-2,771	-0.48%	$88.78	577,536	05 Apr 2022	Direct	F1, F2
transaction	NARI	Common Stock	Sale	$641,766	-7,149	-1.2%	$89.77	570,387	05 Apr 2022	Direct	F1, F3
transaction	NARI	Common Stock	Sale	$1,819,850	-20,080	-3.5%	$90.63	550,307	05 Apr 2022	Direct	F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NARI	Stock Options (Right to buy)	Options Exercise	$12,840	-30,000	-18%	$0.4280^*	140,467	05 Apr 2022	Common Stock	30,000	$0.4280	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
F2	This transaction was executed in multiple trades at prices ranging from $88.20 to $89.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $89.22 to $90.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	This transaction was executed in multiple trades at prices ranging from $90.22 to $91.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5	Option vested with respect to 25% of the underline shares on May 3, 2019 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.